Floatz logo

Eloxatin

Capecitabine

Meng QiuPhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Capecitabine cohort.

Asset / SponsorPhaseRating
Capecitabine
Seoul National University Hospital
Phase 3BB
FLUOROURACILUM
Seoul National University Hospital
Phase 3BB
Calcium folinate pentahydrate
Meng Qiu
Phase 3BB
Cetuximab
Meng Qiu
Phase 3B
rc48-adc
The First Affiliated Hospital of Zhengzhou University
Phase 2/3B

View all 13 →

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →